Oxford University Press (OUP), Journal of Antimicrobial Chemotherapy, 11(69), p. 3119-3126
DOI: 10.1093/jac/dku233
Full text: Download
Treatment of multidrug-resistant Acinetobacter baumannii (MDRAB) infection presents a challenge because of the scarcity of available options. Even though combination therapy (CT) is frequently used in clinical practice, data are needed to support its use instead of monotherapy (MT).